Alpha 2.0
Login Register
» Journals » Eur J Gastroenterol Hepatol

European Journal of Gastroenterology & Hepatology

The European Journal of Gastroenterology & Hepatology is a reputable scientific journal that focuses on the latest research and advancements in the field of gastroenterology and hepatology. It covers a wide range of topics including gastrointestinal diseases, liver disorders, endoscopy, nutrition, and therapeutic interventions. The journal provides a platform for researchers, clinicians, and healthcare professionals to share their findings and contribute to the understanding and management of gastrointestinal and liver-related conditions.
Details
Abbr. Eur J Gastroenterol Hepatol
Start 1989
End Continuing
Frequency Monthly
p-ISSN 0954-691X
e-ISSN 1473-5687
Country United Kingdom
Language English
Specialty Gastroenterology
Metrics
h-index / Ranks: 2450 114
SJR / Ranks: 6343 698
CiteScore / Ranks: 6699 4.00
JIF / Ranks: 5004 2.1
Recent Articles
1.
Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients
Liatsos C, Tzouvala M, Michalopoulos G, Giouleme O, Karmiris K, Kozompoli D, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976073
Background And Aims: Tofacitinib has been approved for the treatment of patients with moderate-to-severe ulcerative colitis independently of prior therapies. We aimed to assess the efficacy and safety of tofacitinib...
2.
Prior overt hepatic encephalopathy and hyponatremia are more strongly linked to recent driving accidents than measures of minimal hepatic encephalopathy
Roy A, Bhattad U, Ranjan V, Chakraborty S, Tewari A, Sonthalia N, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976071
Background: Cognitive impairment in cirrhosis is driven by multiple influencers. Those with cognitive impairment have greater traffic accidents and violations. While the presence of minimal hepatic encephalopathy has been associated...
3.
CD96: immunoregulation and its role and prospect in immunotherapy of primary hepatocellular carcinoma
Chai J, Li L, Wu Q, Zhang S
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976070
Recently, immune checkpoint inhibitors have been widely used in the treatment of advanced liver cancer. Immune checkpoints are a type of molecules that play an important role in the self-regulation...
4.
Metabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma
Alsaqa M, Sierra L, Marenco-Flores A, Parraga X, Barba R, Goyes D, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976068
Background: Direct-acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment. The changing landscape of hepatocellular carcinoma (HCC) in liver transplant (LT) recipients lacks a thorough description of the outcomes...
5.
Comparison of clinical characteristics and outcomes in patients with hepatocellular carcinoma based on serum alpha-fetoprotein status
Li J, Cheng X, Meng Y, Wang M
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976057
Background: Alpha-fetoprotein (AFP) is the most commonly used and crucial tumor marker in clinical diagnosis and prognosis guidance for hepatocellular carcinoma (HCC). However, approximately 30% of HCC patients do not...
6.
Sterile systemic inflammation reaction associated with 90-day mortality in patients with HBV-related acute-on-chronic liver failure
Chen J, Liu X, Guan C, Peng Y, Li C, Yan L, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976056
Background: Acute-on-chronic liver failure (ACLF) represents the terminal and most lethal phase of acute decompensated cirrhosis. Systemic inflammation plays a critical role in the pathogenesis of ACLF. Systemic inflammation reaction...
7.
Prevalence of gastroesophageal reflux disease in adult coeliac disease at diagnosis and during follow-up: a 20-year retrospective study
Maimaris S, Mangili L, Minerba P, Massetti G, Scarcella C, Schiepatti A, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976055
Objective: Gastroesophageal reflux disease (GORD) is commonly reported in coeliac disease (CD). However, long-term data on GORD in coeliac patients on a gluten-free diet (GFD) are lacking. We aimed to...
8.
Clinical outcomes of endoscopic mucosal resection for large superficial nonampullary duodenal epithelial tumor: a single-center study
Barbaro F, Papparella L, Chiappetta M, Schepis T, Maresca R, Del Vecchio L, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976048
Background And Aim: Endoscopic mucosal resection (EMR) of superficial nonampullary duodenal epithelial tumors (SNADETs) is challenging, and to date, only a few studies assessed the clinical outcomes of EMR in...
9.
The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysis
Ojaghi Shirmard F, Pourfaraji S, Saeedian B, Bagheri T, Ismaiel A, Matsumoto S, et al.
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976047
Inflammatory bowel disease (IBD) is a condition of unknown origin. It does not have a definite cure and its response to various treatments can be evaluated based on symptom-based measures,...
10.
Rotational thromboelastometry predicts transplant-free survival in patients with liver cirrhosis
Janko N, Majeed A, Commins I, Gow P, Kemp W, Roberts S
Eur J Gastroenterol Hepatol . 2025 Feb; PMID: 39976046
Background And Aims: Emerging evidence suggests that rotational thromboelastometry (ROTEM) is superior to conventional haemostatic tests in the assessment and management of bleeding risk in patients with cirrhosis. Whether ROTEM...